Search or

𝛼SK

ENTITY

SanBio Co Ltd (4592 JP)

46

Analysis

Health Care • Japan

Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.

more

Refresh

Exchange Announcement • 06 Nov 2025 22:30

Announcement Of Determination Of Issue Price And Other Matters For Issuance Of New Shares Through An International Offering

Exchange Announcement • 06 Nov 2025 15:00

Announcement Of Issuance Of New Shares Through An International Offering

Exchange Announcement • 16 Oct 2025 19:30

Notice Regarding The Subcommittee Review Results On Partial Change Approval For Akuugo [R]

Exchange Announcement • 02 Oct 2025 14:45

Notice Regarding Inclusion Of Akuugo (R) Suspension For Intracranial Implantation On The Committee Agenda

Exchange Announcement • 18 Sep 2025 14:30

Presentation For Financial Results For The 2nd Quarter Of The Fiscal Year Ending January 31, 2026

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x